Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Godfrey M. Bigogo"'
Autor:
Nigel P. French, Kate M. Thomas, Nelson B. Amani, Jackie Benschop, Godfrey M. Bigogo, Sarah Cleaveland, Ahmed Fayaz, Ephrasia A. Hugho, Esron D. Karimuribo, Elizabeth Kasagama, Ruth Maganga, Matayo L. Melubo, Anne C. Midwinter, Blandina T. Mmbaga, Victor V. Mosha, Fadhili I. Mshana, Peninah Munyua, John B. Ochieng, Lynn Rogers, Emmanuel Sindiyo, Emanuel S. Swai, Jennifer R. Verani, Marc-Alain Widdowson, David A. Wilkinson, Rudovick R. Kazwala, John A. Crump, Ruth N. Zadoks
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 10, Pp 2079-2089 (2024)
Campylobacteriosis and antimicrobial resistance (AMR) are global public health concerns. Africa is estimated to have the world’s highest incidence of campylobacteriosis and a relatively high prevalence of AMR in Campylobacter spp. from humans and a
Externí odkaz:
https://doaj.org/article/469e28b1578f42e48ef3af63e8ebc66e
Autor:
Melissa C. Kapulu, Esther Muthumbi, Edward Otieno, Omar Rossi, Pietro Ferruzzi, Francesca Necchi, Alessandra Acquaviva, Laura B. Martin, Benedict Orindi, Kennedy Mwai, Hillary Kibet, Alfred Mwanzu, Godfrey M. Bigogo, Jennifer R. Verani, Cecilia Mbae, Christopher Nyundo, Charles N. Agoti, Usman Nasir Nakakana, Valentino Conti, Philip Bejon, Samuel Kariuki, J. Anthony G. Scott, Francesca Micoli, Audino Podda
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundShigellosis mainly affects children under 5 years of age living in low- and middle-income countries, who are the target population for vaccination. There are, however, limited data available to define the appropriate timing for vaccine admi
Externí odkaz:
https://doaj.org/article/eb6544215e7348a1ae59375e0a39e3f1
Autor:
Nancy A. Otieno, Fauzia A. Malik, Stacy W. Nganga, Winnie N. Wairimu, Dominic O. Ouma, Godfrey M. Bigogo, Sandra S. Chaves, Jennifer R. Verani, Marc-Alain Widdowson, Andrew D. Wilson, Irina Bergenfeld, Ines Gonzalez-Casanova, Saad B. Omer
Publikováno v:
Implementation Science, Vol 16, Iss 1, Pp 1-15 (2021)
Abstract Background Maternal immunization is a key strategy for reducing morbidity and mortality associated with infectious diseases in mothers and their newborns. Recent developments in the science and safety of maternal vaccinations have made possi
Externí odkaz:
https://doaj.org/article/cb5afdb9cfd24b418df607e1efeb5267
Autor:
Mike J. Mwanga, Betty E. Owor, John B. Ochieng, Mwanajuma H. Ngama, Billy Ogwel, Clayton Onyango, Jane Juma, Regina Njeru, Elijah Gicheru, Grieven P. Otieno, Sammy Khagayi, Charles N. Agoti, Godfrey M. Bigogo, Richard Omore, O. Yaw Addo, Seheri Mapaseka, Jacqueline E. Tate, Umesh D. Parashar, Elizabeth Hunsperger, Jennifer R. Verani, Robert F. Breiman, D. James Nokes
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Kenya introduced the monovalent G1P [8] Rotarix® vaccine into the infant immunization schedule in July 2014. We examined trends in rotavirus group A (RVA) genotype distribution pre- (January 2010–June 2014) and post- (July 2014
Externí odkaz:
https://doaj.org/article/03613fb1debe4f228aa55187f987d5b8
Autor:
Marc-Alain Widdowson, Joshua Auko, Daniel R. Feikin, Maria da Gloria Carvalho, Godfrey M. Bigogo, Allan Audi, Cynthia G. Whitney, George Aol, Benjamin J. Ochieng, Arthur Odoyo, Martien W. Borgdorff, Herine Odiembo, Jennifer R. Verani, Clayton Onyango
Publikováno v:
Clinical infectious diseases, 69(12), 2177-2184. Oxford University Press
Background Data on pneumococcal conjugate vaccine (PCV) indirect effects in low-income countries with high human immunodeficiency virus (HIV) burden are limited. We examined adult pneumococcal pneumonia incidence before and after PCV introduction in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0923bd733371223357193d94a2185eb1
https://doi.org/10.1093/cid/ciz139
https://doi.org/10.1093/cid/ciz139
Autor:
Nicole Young, Miriam Taegtmeyer, George Aol, Godfrey M Bigogo, Penelope A Phillips-Howard, Jenny Hill, Kayla F Laserson, Feiko Ter Kuile, Meghna Desai
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0198784 (2018)
BACKGROUND:In sub-Saharan Africa, HIV, syphilis, malaria and anaemia are leading preventable causes of adverse pregnancy outcomes. In Kenya, policy states women should be tested for all four conditions (malaria only if febrile) at first antenatal car
Externí odkaz:
https://doaj.org/article/46399b9b1d154cf8adc5dfd72829af4f
Autor:
Deron C Burton, Godfrey M Bigogo, Allan O Audi, John Williamson, Kenneth Munge, Jackline Wafula, Dominic Ouma, Sammy Khagayi, Isaac Mugoya, James Mburu, Shadrack Muema, Evasius Bauni, Tahreni Bwanaali, Daniel R Feikin, Peter M Ochieng, Ondari D Mogeni, George A Otieno, Beatrice Olack, Tatu Kamau, Melissa K Van Dyke, Robert Chen, Paddy Farrington, Joel M Montgomery, Robert F Breiman, J Anthony G Scott, Kayla F Laserson
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141896 (2015)
There is a theoretical risk of adverse events following immunization with a preservative-free, 2-dose vial formulation of 10-valent-pneumococcal conjugate vaccine (PCV10). We set out to measure this risk. Four population-based surveillance sites in K
Externí odkaz:
https://doaj.org/article/5e78cd43f19b49e3a6a88f7b24e6ef6e
Autor:
Robert F Breiman, Leonard Cosmas, Henry Njuguna, Allan Audi, Beatrice Olack, John B Ochieng, Newton Wamola, Godfrey M Bigogo, George Awiti, Collins W Tabu, Heather Burke, John Williamson, Joseph O Oundo, Eric D Mintz, Daniel R Feikin
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e29119 (2012)
BACKGROUND: High rates of typhoid fever in children in urban settings in Asia have led to focus on childhood immunization in Asian cities, but not in Africa, where data, mostly from rural areas, have shown low disease incidence. We set out to compare
Externí odkaz:
https://doaj.org/article/3edaeade62f74122bffc7a8079989d20
Autor:
Daniel R Feikin, Beatrice Olack, Godfrey M Bigogo, Allan Audi, Leonard Cosmas, Barrack Aura, Heather Burke, M Kariuki Njenga, John Williamson, Robert F Breiman
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16085 (2011)
BackgroundCharacterizing infectious disease burden in Africa is important for prioritizing and targeting limited resources for curative and preventive services and monitoring the impact of interventions.MethodsFrom June 1, 2006 to May 31, 2008, we es
Externí odkaz:
https://doaj.org/article/20d5b0a4e69846d4b6ed64c065fb598f